In support of the link between TME and different genetic background, Yang H and collaborators provided evidence that CD8+ T cells were mainly enriched in the MPM harboring Large Tumor Suppressor Kinase 1⁄2 (LATS1/2 mutation compared with NF2-mutant cancer. The gene discussed is CD8A; the disease is cancer.